• control
• Pharmacology
• June 15, 2024

Investigating the potential of CRISPR-based gene editing for the treatment of Duchenne muscular dystrophy – Complete Phd and Masters Thesis

[ad_1] Introduction Duchenne muscular dystrophy (DMD) is a severe and progressive muscle-wasting disease that affects approximately 1 in 5000 male births worldwide. This genetic disorder is caused by mutations in the dystrophin gene, leading to…